MERSANA THERAPEUTICS

Mersana Therapeutics Chief People Officer Carla Poulson Named One of Savoy Magazine’s 2022 Most Influential Black Executives in Corporate America

22 7 2022 07:00:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

08 7 2022 15:05:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 6 2022 15:05:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Present at Upcoming Investor Conferences

26 5 2022 07:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces FDA Grant of Orphan Drug Designation to XMT-2056 for the Treatment of Gastric Cancer

19 5 2022 06:00:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Provides Business Update and Announces First Quarter 2022 Financial Results

09 5 2022 06:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 5 2022 15:05:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Host First Quarter 2022 Conference Call on May 9, 2022

02 5 2022 07:00:02 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 4 2022 15:05:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Present Preclinical Data on XMT-1660, XMT-2056 and the Immunosynthen Platform at AACR Annual Meeting

05 4 2022 07:00:02 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Present an Analysis from the Expansion Cohort of the Phase 1 Trial of Upifitamab Rilsodotin at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer

15 3 2022 07:00:02 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Present at the Cowen 42nd Annual Health Care Conference

02 3 2022 07:00:02 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

28 2 2022 05:00:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2021 Financial Results and Business Updates

22 2 2022 07:00:02 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

10 2 2022 07:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Research Collaboration and License Agreement with Janssen to Advance Novel Antibody-Drug Conjugates

03 2 2022 06:00:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces 2022 Strategic Priorities and Milestones

07 1 2022 07:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

05 1 2022 07:00:02 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Named to 2021 List of Top Places to Work in Massachusetts by The Boston Globe

02 12 2021 07:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Participate in the Upcoming 4th Annual Evercore ISI HealthCONx Conference

23 11 2021 07:00:01 提供 Nasdaq GlobeNewswire